10 reports

  • 11.6 VIVO CANNABIS INC.
  • 11.2 AURORA CANNABIS INC.

Growing medicinal application of cannabis is expected to drive the overall growth of the cannabis market. The cannabis market size is expected to grow from USD 10.3 billion in 2018 to USD 39.4 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 30.7% during the forecast period. The cannabis market is driven by various factors such...

  • Marijuana
  • Canada
  • Market Size
  • Aphria Inc
  • Canopy Growth Corporation
  • PREMIUM CANNABIS
  • CANNABIS OILS

The legal Cannabis revolution is only beginning. The 80+ years prohibition against its use is now ending and the tides are clearly turning. Despite being illegal for so long, more than 37 million people in the U.S. and millions more in Canada use Cannabis, both legally and illicitly. As a result, the market for Cannabis...

  • Marijuana
  • Canada
  • Demand
  • Aphria Inc
  • Canopy Growth Corporation
  • BUDDING MARKET FOR MEDICAL MARIJUANA
  • DEMOGRAPHICS AND MEDICAL MARIJUANA

Joint venture: Government deregulation and growth in private companies will cause revenue to surge Abstract Cannabis Production in Canada Over the five years to 2018, the Cannabis Production industry has transitioned from a single government-sponsored provider of medical cannabis products...

  • Marijuana
  • Canada
  • Demand
  • Forecast
  • THERAPEUTIC USES OF CANNABIS
  • BEDROCAN CANNABIS CORP. IMPORT FACILITY FEATURES

The objective of this report is to provide a detailed analysis of the global market for Medical Marijuana. It is also to provide a comprehensive analysis of the leading companies producing these products, as well as the competitive environment they operate in. Marijuana (cannabis) remains a controversial drug in the twenty-first century. However,...

  • Marijuana
  • Canada
  • Bedrocan Canada Inc.
  • Cannabis Science, Inc.
  • Medical Marijuana, Inc.
  • Asset Utilization: Supreme Cannabis Company Inc
  • Comparative Business Analysis: Supreme Cannabis Company Inc

A textual analysis of the financial results for Supreme Cannabis Company Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Marijuana
  • Canada
  • United States
  • World
  • Company Financials
  • Mar 11, 2016: Supreme Obtains MMPR License to Cultivate Medical Marijuana
  • Supreme Pharma Raises USD0.53 Million in Private Placement of Shares

Summary Supreme Pharmaceuticals Inc (Supreme Pharmaceuticals), formerly Supreme Resources Ltd is a medial products production and distributing company. The company’s products include medical marijuana, sun grown marijuana and others. It offers services such as production, exploration, trading, cultivation services and others....

  • Healthcare
  • Marijuana
  • Canada
  • Corporate Finance
  • GlobalData's company
  • Feb 16, 2017: Tetra Bio-Pharma Reports Approval by Health Canada of its Phase I Trial of PPP001 (dried Cannabis)
  • Apr 04, 2018: Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study

Cancer Pain - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Pipeline Review, H2 2018, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape. Cancer pain can be defined as a complex...

  • Analgesic
  • Marijuana
  • Pharmaceutical
  • Canada
  • Product Initiative
  • DEAL TYPE
  • LICENSING AGREEMENTS

Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets.The company’s pipeline products include INM-750 and INM-085. Its products...

  • Marijuana
  • Pharmaceutical
  • Canada
  • Company
  • InMed Pharmaceuticals Inc.
  • Deal Information Deal Status Completed Date Deal Financials
  • Deal Information Deal Status Completed Date Deal Financials

Summary Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis.The company extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportunity for use as...

  • Marijuana
  • Canada
  • Company
  • Supply
  • T-Bird Pharma Inc
  • CANNABIS INTRACTABLE - DRUG PROFILE
  • Feb 16, 2017: Tetra Bio-Pharma Reports Approval by Health Canada of its Phase I Trial of PPP001 (dried Cannabis)

Cancer Pain - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Pipeline Review, H1 2018, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape. Cancer pain can be defined as a complex...

  • Marijuana
  • Pharmaceutical
  • Canada
  • Company
  • Product Initiative